| From : | Maia Nikoleishvili <mnikoleishvili@moh.gov.ge> |
| To : | Tamar Gabunia <tgabunia@moh.gov.ge> |
| Subject : | RE: Covax Pfizer Allocation - Georgia |
| Received On : | 02.04.2021 10:39 |
| Attachments : |
ქალბატონო თამუნა,
გიგზავნით ხელმოწერილ
დოკუმენტს, პოზიციისა და სახელი/გვარის მითითებით.
პატივისცემით,
მაიკო
From: Tamar Gabunia [mailto:tgabunia@moh.gov.ge]
Sent: Thursday, April 1, 2021 7:40 PM
To: Maia Nikoleishvili
Subject: RE: Covax Pfizer Allocation - Georgia
მაიკო
მინისტრის სახელი და გვარი და პოზიცია აუცილებლად უნდა მივაწეროთ (ან მივაბეჭდოთ) ჩემი აზრით.
პატივისცემით,
თამარ გაბუნია
მინისტრის პირველი მოადგილე
Sincerely,
Tamar Gabunia,
MD, MPH
First Deputy Minister
From: Maia Nikoleishvili [mailto:mnikoleishvili@moh.gov.ge]
Sent: 1 April, 2021 18:25
To: Tamar Gabunia <tgabunia@moh.gov.ge>
Subject: FW: Covax Pfizer Allocation - Georgia
ქალბატონო თამუნა,
გიგზავნით როუზისთან გასაგზავნ დანართს. მიმოწერაში კოვაქსის მეილიც ჩასვით,
covax@gavi.org
Dear Rosie,
Upon your request I am sending signed Commitment Satisfaction Certificate.
Thank you again for
fruitful collaboration and
support.
Best regards,
From: Tamar Gabunia [mailto:tgabunia@moh.gov.ge]
Sent: Wednesday, March 31, 2021 1:37 PM
To: Rosie Grieves (Consultant) <rgrieves@gavi.org>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>;
Beka Dzamashvili <bdzamashvili@justice.gov.ge>;
sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>
Subject: RE: Covax Pfizer Allocation - Georgia
Dear Rosie
Thanks a lot! This is well received and noted. We will follow up on next steps as advised.
პატივისცემით,
თამარ გაბუნია
მინისტრის პირველი მოადგილე
Sincerely,
Tamar Gabunia,
MD, MPH
First Deputy Minister
From: Rosie Grieves (Consultant) [mailto:rgrieves@gavi.org]
Sent: 31 March, 2021 11:37
To: Tamar Gabunia <tgabunia@moh.gov.ge>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>;
Beka Dzamashvili <bdzamashvili@justice.gov.ge>;
sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>
Subject: RE: Covax Pfizer Allocation - Georgia
Tamar,
My original email referred to another country in the second bullet. I have adjusted.
Apologies for this oversight.
Rosie
From: Rosie Grieves (Consultant)
Sent: 31 March 2021 07:16
To: Tamar Gabunia <tgabunia@moh.gov.ge>
Cc: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Natia Khmaladze <natkhmaladze@moh.gov.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>;
Beka Dzamashvili <bdzamashvili@justice.gov.ge>;
sgagua@gov.ge; Giorgi Tsotskolauri <gtsotskolauri@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>
Subject: Covax Pfizer Allocation - Georgia
Tamar,
We are pleased to confirm that you have been allocated the remainder of your pro-rata Pfizer-BioNTech BNT162b2 vaccines for the period through
June 2021, within the framework of the COVAX Facility.
The attached letter includes the following information:
·
Your allocation of Pfizer-BioNTech BNT162b2 vaccine doses for this period;
·
Next steps that you must ensure for Georgia to successfully access allocated doses .
You will also find attached to this letter a Procurement Costing Annex summarizing procurement price per dose set by Pfizer,
the Actual Procurement Price per dose, and the total purchase value owed by you.
Your allocation is 1170 doses, which brings you to your total pro-rata share of Pfizer-BioNTech BNT 162b2 vaccines. We acknowledge
that it would have been simpler to have given you these at the time of your first shipment. The allocation model assigns average coverage to all countries and this is why it did not happen. However, we have adjusted the model so that if a similar situation
occurs in future allocation rounds, this would be highlighted and the extra tray would be added to the shipment.
The timeframe between the issuance of a purchase order and the delivery arriving in-country may be up to 8 weeks. A Pfizer representative will
be in touch about next steps.
As the attachments contain confidential information, I have not copied partners into this email. I will forward the email to
them without the confidential information, with you in copy, so they are aware of this latest allocation.
As ever, if you require any further clarifications, do not hesitate to contact me.
Best wishes
Rosie
Rosie Grieves
Senior Manager Country Engagement
Mobile: +44 7849 574189
Web: gavi.org
NOTICE: This email, including any attachments to it, may be confidential and does not create any binding contract on behalf
of Gavi or its partners.
If this email was sent to you in error, please notify the send